<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>(S)-Emopamil is a novel <z:chebi fb="1" ids="38215">calcium channel blocker</z:chebi> of the phenylalkylamine class, with potent <z:chebi fb="19" ids="28790">serotonin</z:chebi> S2 <z:chebi fb="68" ids="48706">antagonist</z:chebi> activity </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the effect of (S)-emopamil on the histopathologic consequences of global <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> in anesthetized rats </plain></SENT>
<SENT sid="2" pm="."><plain>Pretreated rats (n = 15) received 20 mg/kg i.p </plain></SENT>
<SENT sid="3" pm="."><plain>(S)-emopamil 30 minutes before and 2 hours following 10 minutes of bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> plus <z:hpo ids='HP_0002615'>arterial hypotension</z:hpo> (50 mm Hg) </plain></SENT>
<SENT sid="4" pm="."><plain>Quantitative cell counts following 3 days' survival revealed a marked loss of pyramidal neurons in <z:hpo ids='HP_0000001'>all</z:hpo> subsectors of the hippocampal CA1 area of untreated ischemic rats (n = 15) </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, in (S)-emopamil pretreated rats numbers of <z:mpath ids='MPATH_458'>normal</z:mpath> neurons were significantly higher, by 2.4-, 1.9-, and 1.8-fold, respectively, in the medial, middle, and lateral subsectors of the CA1 area </plain></SENT>
<SENT sid="6" pm="."><plain>For example, <z:mpath ids='MPATH_458'>normal</z:mpath> neuron counts in the medial CA1 subsector were 34 +/- 9 (mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) in untreated ischemic rats compared with 82 +/- 13 in (S)-emopamil pretreated rats (control nonischemic value [n = 5] 157 +/- 2) </plain></SENT>
<SENT sid="7" pm="."><plain>By semiquantitative grading, (S)-emopamil also decreased ischemic changes in the cerebral cortex </plain></SENT>
<SENT sid="8" pm="."><plain>No significant effect of (S)-emopamil on ischemic injury was detected in rats treated beginning 30 minutes after the ischemic insult (n = 10) </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, pretreatment with (S)-emopamil is beneficial in decreasing the severity of neuronal injury in global <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
</text></document>